Antibiotic Resistance: Opportunities and Challenges

Certain bacterial infections now defy all antibiotics. The resistance problem may be reversible, but only if society begins to consider how the drugs affect "good" bacteria as well as "bad". Historically, most antibacterials were used in hospitals, where they were incorporated into soaps and surgical clothes to limit the spread of infections. More recently, however, those substances (including triclocarbon, triclosan and such quaternary ammonium compounds as benzalkonium chloride) have been mixed into soaps, lotions and dishwashing detergents meant for general consumers. They have also been impregnated into such items as toys, high chairs, mattress pads and cutting boards.

Overall sales in the current antibiotics and new products market were nearly $40 billion in 2008. It increased to $41.5 billion in 2009. By 2015, it is projected to increase to $65.5 billion, for a 5-year compound annual growth rate (CAGR) of 9.6%. The largest segment antibiotic drugs market was nearly $36 billion in 2008; this further increased to $37 billion in 2009, this projected to reach $50 billion in 2015, for a 5-year CAGR of 5.9%. Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2015, for a 5-year CAGR of 31.6%.

  • Antibiotics and alternatives
  • Systemic intervention – values, conflict and blue room resolution
  • Grand challenges – antimicrobial resistance
  • Intervention against antimicrobial resistance – approaches and implementation

Related Conference of Antibiotic Resistance: Opportunities and Challenges

October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 05-07, 2018

18th Annual Pharma Middle East Congress

Radisson Blu Hotel, Yas Island, Abu Dhabi, UAE
November 14-15, 2018

13th World Congress on Pharmacology and Toxicology

Melbourne, Australia
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Berlin, Germany
January 30-31, 2019

19th World Congress on Advances in Pharmaceutical Sciences

Seoul, South Korea
February 20-21, 2019

World Congress on Drug Discovery and Drug Design

Singapore
February 22-23, 2019

13th World Drug Delivery Summit

San Francisco, USA
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
March 27-28, 2019

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
April 04-06, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Auckland, NewZealand
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
April 17-18, 2019

International Conference on Global Analytica

Osaka, Japan

May 9-11, 2019

11th World Congress on Neuropharmacology

Prague, Czech Republic
May 20-22, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
March 22-23, 2019

5th International Conference on Antibiotics

Orlando, USA
June 17-18, 2019

7 th European Biopharma Congress

Stockholm, Sweden
June 17-18, 2019

14th World Congress on Pharmacology and Drug Safety

Lisbon, Portugal
June 27-29, 2019

18th Annual Congress on Pharmaceutics & Drug Delivery Systems

Amsterdam, Netherlands
July 19-20, 2019

8th International Conference on Clinical Trials

| Atlanta, USA

August 19-20, 2019

24th World Congress on Pharmacology

Vienna, Austria

Antibiotic Resistance: Opportunities and Challenges Conference Speakers

Recommended Sessions

Related Journals

Are you interested in